DHA supplementation improved both memory and reaction time in healthy young adults: A randomized controlled trial

American Journal of Clinical Nutrition

Volumn 97, Issue 5, 2013, Pages 1134-1143

  Stonehouse, Welma ^a   Conlon, Cathryn A ^a   Podd, John ^b   Hill, Stephen R ^b   Minihane, Anne M ^c   Haskell, Crystal ^d   Kennedy, David ^d  

^a MASSEY UNIVERSITY   (New Zealand)

^b MASSEY UNIVERSITY   (New Zealand)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d NORTHUMBRIA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LINOLEIC ACID; OLEIC ACID; PALMITIC ACID; PLACEBO; STEARIC ACID;

ADULT; APTITUDE TEST; ARTICLE; ATTENTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; EPISODIC MEMORY; FEMALE; FOLLOW UP; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY;

ADOLESCENT; ADULT; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; FOOD HABITS; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEW ZEALAND; REACTION TIME; YOUNG ADULT;

EID: 84876937682     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.053371     Document Type: Article

References (51)

1. Horrocks LA, Farooqui AA. Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot Essent Fatty Acids 2004;70:361-72.
2. Innis SM. Dietary (n23) fatty acids and brain development. J Nutr 2007;137:855-9.
3. Tassoni D, Kaur G, Weisinger RS, Sinclair AJ. The role of eicosanoids in the brain. Asia Pac J Clin Nutr 2008;17:220-8.
4. Chung WL, Chen JJ, Su HM. Fish oil supplementation of control and (n23) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. J Nutr 2008;138:1165-71.
5. Gamoh S, Hashimoto M, Sugioka K, Hossain MS, Hata N, Misawa Y, Masumura S. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Neuroscience 1999;93:237-41.
6. University of Otago. Ministry of health. a focus on nutrition: key findings of the 2008/2009 New Zealand Adult Nutrition Survey. Wellington: Ministry of Health, 2011.
7. Richardson AJ, Montgomery P. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 2005;115:1360-6.
8. Sinn N, Bryan J, Wilson C. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial. Prostaglandins Leukot Essent Fatty Acids 2008;78:311-26.
9. Dangour AD, Allen E, Elbourne D, Fasey N, Fletcher AE, Hardy P, Holder GE, Knight R, Letley L, Richards M, et al. Effect of 2-y n23 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 2010;91:1725-32.
10. van de Rest O, Geleijnse JM, Kok FJ, van StaverenWA, Dullemeijer C, Olderikkert MG, Beekman AT, de Groot CP. Effect of fish oil on cognitive performance in older subjects - a randomized, controlled trial. Neurology 2008;71:430-8.
11. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr., Stedman M. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010;6:456-64.
12. Antypa N, Van der Does AJW, Smelt AHM, Rogers RD. Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. J Psychopharmacol 2009;23:831-40.
13. Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L. Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 2005; 35:691-9.
14. Jackson PA, Reay JL, Scholey AB, Kennedy DO. DHA-rich oil modulates the cerebral haemodynamic response to cognitive tasks in healthy young adults: a near IR spectroscopy pilot study. Br J Nutr 2012;107:1093-8.
15. Jackson PA, Deary ME, Reay JL, Scholey AB, Kennedy DO. No effect of 12 weeks' supplementation with 1 g DHA-rich or EPA-rich fish oil on cognitive function or mood in healthy young adults aged 18-35 years. Br J Nutr 2012;107:1232-43.
16. Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, Hayward RC, Heatherley SV, Christian LM, McNaughton SA, Ness AR. No effect of n23 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr 2008;99:421-31.
17. Duff SJ, Hampson E. A sex difference on a novel spatial working memory task in humans. Brain Cogn 2001;47:470-93.
18. Herlitz A, Rehnman J. Sex differences in episodic memory. Curr Dir Psychol Sci 2008;17:52-6.
19. Guillem F, Mograss M. Gender differences in memory processing: evidence from event-related potentials to faces. Brain Cogn 2005;57: 84-92.
20. Speck O, Ernst T, Braun J, Koch C, Miller E, Chang L. Gender differences in the functional organization of the brain for working memory. Neuroreport 2000;11:2581-5.
21. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007;39:17-23.
22. FarrerLA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease - a meta-analysis. JAMA 1997;278:1349-56.
23. Wisdom NM, Callahan JL, Hawkins KA. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol Aging 2011;32:63-74.
24. Jorm AF, Mather KA, Butterworth P, Anstey KJ, Christensen H, Easteal S. APOE genotype and cognitive functioning in a large agestratified population sample. Neuropsychology 2007;21:1-8.
25. Alexander DM, Williams LM, Gatt JM, Dobson-Stone C, Kuan SA, Todd EG, Schofield PR, Cooper NJ, Gordon E. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biol Psychol 2007;75:229-38.
26. Mondadori CRA, de Quervain DJF, Buchmann A, Mustovic H, Wollmer MA, Schmidt CF, Boesiger P, Hock C, Nitsch RM, Papassotiropoulos A, et al. Better memory and neural efficiency in young apolipoprotein E epsilon 4 carriers. Cereb Cortex 2007;17: 1934-47.
27. Dennis NA, Browndyke JN, Stokes J, Need A, Buke JR, Welsh- Bohmer KA, Cabeza R. Temporal lobe functional activity and connectivity in young adult APOE epsilon 4 carriers. Alzheimers Dement 2010;6:303-11.
28. Filippini N, Ebmeier KP, MacIntosh BJ, Trachtenberg AJ, Frisoni GB, Wilcock GK, Beckmann CF, Smith SM, Matthews PM, Mackay CE. Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage 2011;54:602-10.
29. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE. Distinct patterns of brain activity in young carriers of the APOE-epsilon 4 allele. Proc Natl Acad Sci USA 2009;106:7209-14.
30. Reiman EM, Chen KW, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004;101:284-9.
31. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alperovitch A. Dietary patterns and risk of dementia - the Three-City cohort study. Neurology 2007;69:1921-30.
32. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR, Weiner M, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease a randomized trial. JAMA 2010;304:1903-11.
33. Samieri C, Feart C, Proust-Lima C, Peuchant E, Dartigues JF, Amieva H, Barberger-Gateau P. Omega-3 fatty acids and cognitive decline: modulation by ApoEe4 allele and depression. Neurobiol Aging 2011 32:2317.e13-22.
34. Whalley LJ, Deary IJ, Starr JM, Wahle KW, Rance KA, Bourne VJ, Fox HC. n23 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr 2008;87:449-54.
35. The New Zealand Institute for Plant & Food Research, New Zealand Ministry of Health. New Zealand FOODfiles 2010. Palmerston North, New Zealand. The New Zealand Institute for Plant & Food Research Ltd, 2010.
36. Kuratko CN, Salem N. Biomarkers of DHA status. Prostaglandins Leukot Essent Fatty Acids 2009;81:111-8.
37. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 1997;38:2012-22.
38. Freeman MP, Sinha P. Tolerability of omega-3 fatty acid supplements in perinatal women. Prostaglandins Leukot Essent Fatty Acids 2007; 77:203-8.
39. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein-E by gene amplification and cleavage with HHAI. J Lipid Res 1990;31:545-8.
40. Stonehouse W, Kruger A, Smuts CM, Loots DT, Wentzel-Viljoen E, Vorster HH. Plasma polyunsaturated fatty acids and liver enzymes in HIV-infected subjects: the Prospective Urban and Rural Epidemiology (PURE) Study. Am J Clin Nutr 2010;91:729-35.
41. Society AOCs. Official methods and recommended practice of the American Oil Chemists' Society. 5th ed. Champaign, IL: AOCS Press, 1993.
42. Sukhija P, Palmquist D. Rapid method for determination of total fatty acid content and composition of feedstuffs and feces. J Agric Food Chem 1988;204:608-1.
43. Kennedy DO, Haskell CF. Cerebral blood flow and behavioural effects of caffeine in habitual and non-habitual consumers of caffeine: a near infrared spectroscopy study. Biol Psychol 2011;86:298-306.
44. Kennedy DO, Veasey R, Watson A, Dodd F, Jones E, Maggini S, Haskell CF. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology (Berl) 2010;211:55-68.
45. Ekstrom RB, French JW, Harman HH, Dermen D. Manual for kit of factor-referenced cognitive tests. Pinceton, NJ: Educational Testing Service, 1976.
46. Wechsler D.WAIS-III administration and scoring manual. San Antonio, CA: Psychological Corporation, 1997.
47. Faul F, Erdfelder E, Lang AG, Buchner AG. Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-91.
48. Schmitt JAJ, Benton D, Kallus KW. General methodological considerations for the assessment of nutritional influences on human cognitive functions. Eur J Nutr 2005;44:459-64.
49. Cunnane SC, Plourde M, Pifferi F, Begin M, Feart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 2009;48:239-56.
50. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MM. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 2002;59:746-8.
51. Wishart HA, Saykin AJ, McAllister TW, Rabin LA, McDonald BC, Flashman LA, Roth RM, Mamourian AC, Tsongalis GJ, Rhodes CH. Regional brain atrophy in cognitively intact adults with a single APOE epsilon 4 allele. Neurology 2006;67:1221-4.